Picture of IDL Diagnostics AB (publ) logo

IDLDX — IDL Diagnostics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Arocell Enters Into Partnership With Zecen Biotech For Distribution In China

Dec 21 (Reuters) - AroCell AB (publ)  AROC.ST :
    * AROCELL ENTERS INTO A PARTNERSHIP WITH ZECEN BIOTECH FOR
DISTRIBUTION IN CHINA
    * SIGNED A SUPPLY AND LICENSE AGREEMENT WITH ZECEN BIOTECH
FOR
DISTRIBUTION OF PRODUCT TPS® CLIA ON THEIR AUTOMATED PLATFORMS
ON CHINESE MARKET
    * PRODUCT IS PLANNED TO BE AVAILABLE IN CHINESE MARKET BY
END OF
2022
    * ACCORDING TO AGREEMENT, ZECEN BIOTECH WILL PAY A ROYALTY
TO
AROCELL BASED ON SALES IN CHINA.

Source text for Eikon:  ID:nMFN7l4Vz7 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on IDL Diagnostics AB (publ)

See all news